{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T14:53:25Z","timestamp":1792508005279,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.ejpb.2022.02.003","type":"journal-article","created":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T12:43:54Z","timestamp":1644237834000},"page":"78-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Nanostructured lipid carriers loaded with an association of minoxidil and latanoprost for targeted topical therapy of alopecia"],"prefix":"10.1016","volume":"172","author":[{"given":"Paula M.","family":"Oliveira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thuany","family":"Alencar-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe Q.","family":"Pires","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcilio","family":"Cunha-Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tais","family":"Gratieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana Lott","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme M.","family":"Gelfuso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2022.02.003_b0005","doi-asserted-by":"crossref","first-page":"485","DOI":"10.2147\/CCID.S284435","article-title":"Topical treatment for scarring and non-scarring alopecia: an overview of the current evidence","volume":"14","author":"Cardoso","year":"2021","journal-title":"Clin. Cosmet. Investig. Dermatol."},{"issue":"8","key":"10.1016\/j.ejpb.2022.02.003_b0010","doi-asserted-by":"crossref","first-page":"593","DOI":"10.4155\/tde-2018-0025","article-title":"Nanotechnology advances for hair loss","volume":"9","author":"Pereira","year":"2018","journal-title":"Ther. Deliv."},{"issue":"4","key":"10.1016\/j.ejpb.2022.02.003_b0015","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1159\/000488011","article-title":"Use of minoxidil sulfate versus minoxidil base in androgenetic alopecia treatment: friend or foe?","volume":"4","author":"Dias","year":"2018","journal-title":"Skin Appendage Disorders."},{"issue":"2","key":"10.1016\/j.ejpb.2022.02.003_b0020","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s40257-018-0409-y","article-title":"Off-label use of topical minoxidil in alopecia: a review","volume":"20","author":"Stoehr","year":"2019","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.ejpb.2022.02.003_b0025","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ijbiomac.2015.01.036","article-title":"Chitosan nanoparticles for targeting and sustaining minoxidil sulphate delivery to hair follicles","volume":"75","author":"Matos","year":"2015","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejpb.2022.02.003_b0030","doi-asserted-by":"crossref","first-page":"100050","DOI":"10.1016\/j.medidd.2020.100050","article-title":"Simultaneous determination of minoxidil and minoxidil sulfate by high-performance liquid chromatography with UV-detection and its applications","volume":"7","author":"Ichida","year":"2020","journal-title":"Med. Drug Discovery."},{"key":"10.1016\/j.ejpb.2022.02.003_b0035","doi-asserted-by":"crossref","first-page":"7921","DOI":"10.2147\/IJN.S225496","article-title":"Drug delivery system based on minoxidil nanoparticles promotes hair growth in C57BL\/6 mice","volume":"14","author":"Nagai","year":"2019","journal-title":"Int. J. Nanomedicine."},{"key":"10.1016\/j.ejpb.2022.02.003_b0040","first-page":"217","article-title":"Minoxidil-encapsulated poly(L-lactide-co-glycolide) nanoparticles with hair follicle delivery properties prepared using W\/O\/W solvent evaporation and sonication","volume":"29","author":"Takeuchi","year":"2018","journal-title":"Biomed. Mater. Eng."},{"issue":"2","key":"10.1016\/j.ejpb.2022.02.003_b0045","doi-asserted-by":"crossref","first-page":"105","DOI":"10.3109\/08982100903161449","article-title":"Development and characterization of minoxidil-loaded liposomal system for delivery to pilosebaceous units","volume":"20","author":"Jain","year":"2010","journal-title":"J. Liposome Res."},{"key":"10.1016\/j.ejpb.2022.02.003_b0050","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.3109\/10837450.2012.685661","article-title":"Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil: in vitro evaluation of drug permeation by infrared spectroscopy","volume":"18","author":"Mura","year":"2013","journal-title":"Pharm. Dev. Technol."},{"issue":"6","key":"10.1016\/j.ejpb.2022.02.003_b0055","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.nano.2015.04.009","article-title":"Anti-PDGF receptor \u03b2 antibody-conjugated squarticles loaded with minoxidil for alopecia treatment by targeting hair follicles and dermal papilla cells","volume":"11","author":"Aljuffali","year":"2015","journal-title":"Nanomedicine."},{"key":"10.1016\/j.ejpb.2022.02.003_b0060","first-page":"300","article-title":"Solid lipid nanoparticles suspension versus commercial solutions for dermal delivery of minoxidil","volume":"416","author":"Padois","year":"2011","journal-title":"Int. J. Pharm."},{"issue":"Suppl 1","key":"10.1016\/j.ejpb.2022.02.003_b0065","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.1016\/S0039-6257(02)00307-7","article-title":"Prostaglandin-induced hair growth","volume":"47","author":"Johnstone","year":"2002","journal-title":"Surv. Ophthalmol."},{"issue":"9","key":"10.1016\/j.ejpb.2022.02.003_b0070","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/IJG.0b013e318259b47c","article-title":"An evaluation of therapeutic noninferiority of 0.005% latanoprost ophthalmic solution and xalatan in patients with glaucoma or ocular hypertension","volume":"22","author":"Digiuni","year":"2013","journal-title":"J. Glaucoma."},{"key":"10.1016\/j.ejpb.2022.02.003_b0075","article-title":"Latanoprost in the treatment of glaucoma","volume":"1967","author":"Stolz","year":"2014","journal-title":"Clin. Ophthalmol."},{"issue":"5","key":"10.1016\/j.ejpb.2022.02.003_b0080","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.0906-6705.2005.00270.x","article-title":"Influence of prostaglandin F2alpha and its analogues on hair regrowth and follicular melanogenesis in a murine model","volume":"14","author":"Sasaki","year":"2005","journal-title":"Exp. Dermatol."},{"issue":"5","key":"10.1016\/j.ejpb.2022.02.003_b0085","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1517\/14656566.2012.662219","article-title":"A review of the use of latanoprost for glaucoma since its launch","volume":"13","author":"Digiuni","year":"2012","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.ejpb.2022.02.003_b0090","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.nano.2015.09.004","article-title":"Nanostructured lipid carriers: promising drug delivery systems for future clinics","volume":"12","author":"Beloqui","year":"2016","journal-title":"Nanomedicine."},{"key":"10.1016\/j.ejpb.2022.02.003_b0095","doi-asserted-by":"crossref","first-page":"111448","DOI":"10.1016\/j.colsurfb.2020.111448","article-title":"Nanostructured lipid carriers for hair follicle-targeted delivery of clindamycin and rifampicin to hidradenitis suppurativa treatment","volume":"197","author":"Pereira","year":"2021","journal-title":"Colloids Surf. B Biointerfaces."},{"key":"10.1016\/j.ejpb.2022.02.003_b0100","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41598-019-56760-w","article-title":"Effect of physical stimuli on hair follicle deposition of clobetasol-loaded lipid nanocarriers","volume":"10","author":"Angelo","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejpb.2022.02.003_b0105","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.colsurfb.2018.06.037","article-title":"The role of formulation and follicular pathway in voriconazole cutaneous delivery from liposomes and nanostructured lipid carriers","volume":"170","author":"Santos","year":"2018","journal-title":"Colloids Surf. B Biointerfaces."},{"key":"10.1016\/j.ejpb.2022.02.003_b0110","doi-asserted-by":"crossref","first-page":"101895","DOI":"10.1016\/j.jddst.2020.101895","article-title":"The influence of sebaceous content on the performance of nanosystems designed for the treatment of follicular diseases","volume":"59","author":"Tolentino","year":"2020","journal-title":"J. Drug Deliv. Sci. Technol."},{"key":"10.1016\/j.ejpb.2022.02.003_b0115","doi-asserted-by":"crossref","first-page":"113373","DOI":"10.1016\/j.jpba.2020.113373","article-title":"LC-MS bioanalytical method for simultaneous determination of latanoprost and minoxidil in the skin","volume":"187","author":"Oliveira","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"6","key":"10.1016\/j.ejpb.2022.02.003_b0120","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/jphp.12543","article-title":"Clobetasol-loaded nanostructured lipid carriers for epidermal targeting","volume":"68","author":"Silva","year":"2016","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejpb.2022.02.003_b0125","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1136\/adc.58.11.911","article-title":"Hunter\u2019s disease in a girl: association with X:5 chromosomal translocation disrupting the Hunter gene","volume":"58","author":"Mossman","year":"1983","journal-title":"Arch. Dis. Child."},{"issue":"11","key":"10.1016\/j.ejpb.2022.02.003_b0130","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1002\/term.2953","article-title":"IDR-1018 induces cell proliferation, migration, and reparative gene expression in 2D culture and 3D human skin equivalents","volume":"13","author":"Alencar\u2010Silva","year":"2019","journal-title":"J. Tissue Eng. Regen. Med."},{"key":"10.1016\/j.ejpb.2022.02.003_b0135","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/nprot.2007.30","article-title":"In vitro scratch assay: a convenient and inexpensive method for analysis of cell migration in vitro","volume":"2","author":"Liang","year":"2007","journal-title":"Nat. Protoc."},{"issue":"3","key":"10.1016\/j.ejpb.2022.02.003_b0140","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0887-2333(94)90170-8","article-title":"Comparative study of the HET-CAM test and the Draize eye test for assessment of irritancy potential","volume":"8","author":"Vinardell","year":"1994","journal-title":"Toxicol. In Vitro."},{"key":"10.1016\/j.ejpb.2022.02.003_b0145","first-page":"415","article-title":"A first vascularized skin equivalent as an alternative to animal experimentation","volume":"33","author":"Groeber","year":"2016","journal-title":"ALTEX."},{"issue":"3","key":"10.1016\/j.ejpb.2022.02.003_b0150","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1007\/s10973-013-2946-1","article-title":"Hydration and drying of various polysaccharides studied using DSC","volume":"113","author":"Ml\u010doch","year":"2013","journal-title":"J. Thermal Anal. Calorimetry."},{"issue":"2","key":"10.1016\/j.ejpb.2022.02.003_b0155","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1590\/S1984-82502010000200022","article-title":"Thermal behavior and decomposition kinetics of rifampicin polymorphs under isothermal and non-isothermal conditions","volume":"46","author":"Alves","year":"2010","journal-title":"Braz. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2022.02.003_b0160","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.addr.2017.08.006","article-title":"Experimental cocrystal screening and solution based scale-up cocrystallization methods","volume":"117","author":"Malamatari","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"7","key":"10.1016\/j.ejpb.2022.02.003_b0165","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.foodres.2008.05.009","article-title":"Characterization of melting properties in dark chocolates from varying particle size distribution and composition using differential scanning calorimetry","volume":"41","author":"Afoakwa","year":"2008","journal-title":"Food Res. Int."},{"key":"10.1016\/j.ejpb.2022.02.003_b0170","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jpba.2017.01.037","article-title":"Use of mixture design in drug-excipient compatibility determinations: Thymol nanoparticles case study","volume":"137","author":"Pires","year":"2017","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejpb.2022.02.003_b0175","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ejps.2016.10.016","article-title":"Solid effervescent formulations as new approach for topical minoxidil delivery","volume":"96","author":"Pereira","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"issue":"5","key":"10.1016\/j.ejpb.2022.02.003_b0180","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1080\/03639045.2020.1755305","article-title":"Latanoprost niosomes as a sustained release ocular delivery system for the management of glaucoma","volume":"46","author":"Fathalla","year":"2020","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2022.02.003_b0185","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ejpb.2015.04.032","article-title":"New prostaglandin analog formulation for glaucoma treatment containing cyclodextrins for improved stability, solubility and ocular tolerance","volume":"95","author":"Rodriguez-Aller","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2022.02.003_b0190","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3390\/pharmaceutics11080397","article-title":"Short term stability testing of efavirenz-loaded solid lipid nanoparticle (SLN) and nanostructured lipid carrier (NLC) dispersions","volume":"11","author":"Makoni","year":"2019","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.ejpb.2022.02.003_b0195","doi-asserted-by":"crossref","first-page":"160","DOI":"10.18433\/jpps29394","article-title":"Evaluation of Ion-pair Formation of Adefovir to Improve Permeation across Artificial and Biological Membranes","volume":"21","author":"Darsazan","year":"2018","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2022.02.003_b0200","doi-asserted-by":"crossref","first-page":"110382","DOI":"10.1016\/j.colsurfb.2019.110382","article-title":"Lipid nanoparticles as carriers of cyclodextrin inclusion complexes: A promising approach for cutaneous delivery of a volatile essential oil","volume":"182","author":"Pires","year":"2019","journal-title":"Colloids Surf. B Biointerfaces."},{"issue":"5","key":"10.1016\/j.ejpb.2022.02.003_b0205","doi-asserted-by":"crossref","first-page":"599","DOI":"10.4103\/0378-6323.100567","article-title":"Development of melanocye-keratinocyte co-culture model for controls and vitiligo to assess regulators of pigmentation and melanocytes","volume":"78","author":"Parsad","year":"2012","journal-title":"Indian J. Dermatol. Venereol. Leprol."},{"issue":"1","key":"10.1016\/j.ejpb.2022.02.003_b0210","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3390\/ijms19010053","article-title":"Minoxidil induction of VEGF is mediated by inhibition of HIF-prolyl hydroxylase","volume":"19","author":"Yum","year":"2017","journal-title":"Int. J. Mol. Sci."},{"issue":"4","key":"10.1016\/j.ejpb.2022.02.003_b0215","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1080\/02713683.2016.1225770","article-title":"Cytotoxic effect of latanoprost on human corneal stromal cells in vitro and its possible mechanisms","volume":"42","author":"Shen","year":"2017","journal-title":"Curr. Eye Res."},{"issue":"5","key":"10.1016\/j.ejpb.2022.02.003_b0220","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/ics.12489","article-title":"Review of hair follicle dermal papilla cells as in vitro screening model for hair growth","volume":"40","author":"Madaan","year":"2018","journal-title":"Int. J. Cosmet. Sci."},{"key":"10.1016\/j.ejpb.2022.02.003_b0225","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3390\/ijms19030691","article-title":"Minoxidil promotes hair growth through stimulation of growth factor release from adipose-derived stem cells","volume":"19","author":"Choi","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejpb.2022.02.003_b0230","doi-asserted-by":"crossref","first-page":"118484","DOI":"10.1016\/j.ijpharm.2019.118484","article-title":"Preclinical safety of topically administered nanostructured lipid carriers (NLC) for wound healing application: biodistribution and toxicity studies","volume":"569","author":"Vairo","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2022.02.003_b0235","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.pharep.2018.10.008","article-title":"Nanostructured lipid carriers: a potential use for skin drug delivery systems","volume":"71","author":"Czajkowska-Ko\u015bnik","year":"2019","journal-title":"Pharmacol. Rep."},{"issue":"3","key":"10.1016\/j.ejpb.2022.02.003_b0240","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1039\/C7NR07706H","article-title":"Selective delivery of adapalene to the human hair follicle under finite dose conditions using polymeric micelle nanocarriers","volume":"10","author":"Kandekar","year":"2018","journal-title":"Nanoscale."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641122000248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641122000248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T16:47:13Z","timestamp":1760546833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641122000248"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":48,"alternative-id":["S0939641122000248"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2022.02.003","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanostructured lipid carriers loaded with an association of minoxidil and latanoprost for targeted topical therapy of alopecia","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2022.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}